Recent data from the European Centre for Disease Prevention and Control (ECDC) highlights a worrying increase in sexually transmitted infections (STIs) across Europe (29 EU/EEA countries).
In 2023, European countries reported nearly 100,000 confirmed cases of gonorrhea, marking a 31% rise from 2022 and an alarming increase of over 300% compared to 2014. Syphilis cases also continued to grow, with 41,051 confirmed cases in 2023- 13% more than in 2022 and twice as many as in 2014.
Although the rise in chlamydia cases slowed in 2023, it remains the most frequently reported bacterial STI in Europe. With over 230,000 cases recorded that year, the number has increased by 13% since 2014.
Beyond the growing number of STI cases, the increasing threat of antimicrobial resistance (AMR) in gonorrhea is particularly concerning. The emergence of drug-resistant strains endangers current treatment options, highlighting the urgency of preventive measures and responsible antibiotic use.
Several factors may explain this surge in STI cases. Increased testing could be one reason, while other possibilities, such as changes in sexual behaviors, including reduced use of protection and a greater number of sexual partners, require further investigation.
These findings underscore a significant rise in syphilis, gonorrhea, and chlamydia, emphasizing the need for greater awareness, improved diagnostic tools, and timely interventions. Immediate action is essential to curb transmission and minimize the public health impact of STIs.
Common Sexually Transmitted Infections and Pathogens
The Role of Real-Time PCR in STI Diagnosis
Early and precise diagnosis is essential to managing and controlling the spread of STIs. Real-Time PCR (Polymerase Chain Reaction) technology offers high sensitivity and specificity, enabling the detection of even low levels of pathogenic DNA.
Anatolia provides advanced molecular diagnostic solutions with its Bosphore Real-Time PCR kits against STI causing pathogens. Bosphore STDs Panel Kits can facilitate the rapid and accurate detection of the most common pathogens in one test, ensuring effective infection management.
With the increasing burden of STIs, reliable molecular diagnostic tools like Real-Time PCR are critical for effective disease management and prevention. Anatolia remains committed to providing cutting-edge solutions to support healthcare professionals in the fight against STIs.
